Marathon Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Marathon Wealth Advisors's ABBV Position: Q3 2026 in Review
Marathon Wealth Advisors reduced its AbbVie (ABBV) stake by 0.61% in Q3 2026, selling an estimated $19.2K and leaving 12,217 shares worth $3.2M. The position accounts for 1.08% of the portfolio, ranked #32.
Marathon Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Marathon Wealth Advisors held 12,217 shares of AbbVie worth $3.2M as of Q3 2026.
- Marathon Wealth Advisors sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
- AbbVie made up 1.08% of Marathon Wealth Advisors's portfolio in Q3 2026, its #32 holding.
- Marathon Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Marathon Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.